Hostname: page-component-7bb8b95d7b-w7rtg Total loading time: 0 Render date: 2024-09-18T00:38:55.911Z Has data issue: false hasContentIssue false
  • English
  • Français

Optic Neuritis and Myelopathy in Systemic Lupus Erythematosus

Published online by Cambridge University Press:  18 September 2015

Stephen Oppenheimer  and
B.I. Hoffbrand
Stephen Oppenheimer*
Affiliation:
Department of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland
B.I. Hoffbrand
Affiliation:
Department of Medicine, The Whittington Hospital, London, England
*
Department of Clinical Neurological Sciences, University Hospital, 339 Windermere Road, P.O. Box 5339, London, Ontario, Canada N6A 5A5
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The optic neuritis of systemic lupus erythematosus (S.L.E.) more frequently results in the persistence of a central scotoma or complete blindness after a single attack than demyelinating optic neuritis, although the initial clinical presentations may be identical. A significant number of patients, however, recover normal vision. Optic neuritis may be the presenting symptom of S.L.E. and as myelopathy may also occur in the course of the disease, confusion with multiple sclerosis may result, especially if there are no arthritic, cutaneous nor visceral manifestations. We report a case of lupus optic neuritis associated with anticardiolipin antibodies and a circulating lupus anticoagulant and suggest these may be a marker for vasculitic optic neuritis and play a role in its aetiology.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 13 , Issue 2 , May 1986 , pp. 129 - 132
Copyright
Copyright © Canadian Neurological Sciences Federation 1986

References

REFERENCES

1.Bishko, F.Retinopathy in systemic lupus erythematosus. Arthritis and Rheumatism 1972; 15: 57–63.CrossRefGoogle ScholarPubMed
2.Hackett, ER, Martinez, RD, Larson, PF, Paddison, RM.Optic neuritis in systemic lupus erythematosus. Arch Neurol 1974; 31: 9–11.CrossRefGoogle ScholarPubMed
3.Smith, CA, Pinals, RS.Optic neuritis in systemic lupus erythematosus. J Rheumatol 1982; 9: 963–966.Google ScholarPubMed
4.Hughes, GRV.Thrombosis, abortion, cerebral disease and the lupus anticoagulant. B.M.J. 1983; 287: 1088–1089.CrossRefGoogle ScholarPubMed
5.Harris, EN, Boey, EL, Mackworth-Young, CG, Hughes, GRVet al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 1211–1214.CrossRefGoogle ScholarPubMed
6.Harris, EN, Hughes, GRV.Cerebral infarction in systemic lupus erythematosus: association with anticardiolipin antibodies. Clin & Exp Rheumatology 1984; 2: 47–51.Google ScholarPubMed
7.Gould, ES, Bird, AC, Leaver, PK, Mcdonald, Wl.Treatment of optic neuritis by retrobulbar injection of triamcinalone. B.M.J. 1977; 1495–1497.CrossRefGoogle Scholar
8.Burde, RM, Keltner, JL, Gittinger, JW, Miller, NR.Optic neuritis etiology? Survey of Ophthalmology 1980; 24: 307–314.CrossRefGoogle ScholarPubMed
9.Dutton, JJ, Burde, RM, Klingele, TG.Autoimmune retrobulbar optic neuritis. Am J Ophthalmology 1982: 94: 11–17.CrossRefGoogle ScholarPubMed
10.Contamin, F, Singer, B, Mignot, B, Mougeot-Martin, Met al. Sur un cas de lupus erythemateux dissemine avec atteinte de la moelle epiniere et des deux nerfs optiques. Ann Med Interne 1978; 129: 463–469.Google Scholar
11.Saraux, H, Laroche, L, Foels, A, Martin-Gousset. Ischemie aigue posterieure du nerf optique. J Fr Ophthalmologic 1982; 5: 167–171.Google Scholar
12.Tan, EM, Cohen, AS, Fries, JF.The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis and Rheumatism 1982; 25: 1271–1277.CrossRefGoogle ScholarPubMed
13.April, RS, Vansonnenberg, E.A case of neuromyelitis optica (Devicr’s Syndrome) in systemic lupus erythematosus. Neurology 1976; 26: 1066–1070.CrossRefGoogle ScholarPubMed
14.Leibold, JE.Ocular toxicity of ethambutol and its relation to dose. Ann NY Acad Sci 1966; 135: 904–909.CrossRefGoogle ScholarPubMed
15.Lessel, S.The Neuro-ophthalmology of S.L.E. Documenta oph thalmologica 1979; 47: 13–42.CrossRefGoogle Scholar
16.Cinefro, RJ, Frenkel, M.Systemic lupus erythematosus presenting as optic neuritis. Ann Ophthalmology 1978; 10: 559–563.Google ScholarPubMed
17.Allen, IV, Millar, JHD, Kirk, J, Shillington, RKA.Systemic lupus erythematosus, clinically resembling multiple sclerosis and with unusual pathological and ultrastructural features. J Neurol Neurosurg Psychiatry 1979; 42: 392–401.CrossRefGoogle ScholarPubMed
18.Hayreh, SS.Posterior ischemic optic neuropathy. Ophthalmologic Basle 1981; 182: 2–41.Google ScholarPubMed
19.Vitale, C, Kahn, MF, de Seze, M, de Seze, S.Nevrite optique, myelite et maladie lupique. Ann Med Interne 1973: 124: 211–216.Google Scholar
20.Lubbe, WF, Butler, WS, Palmer, Jet al. Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1983:1361–1363.CrossRefGoogle ScholarPubMed
21.Byron, MA.The Clotting Defect in S.L.E. Clinics in Rheumatic Diseases 1982; 8, No 1.Google Scholar
22.Carreras, LD, Defreyn, G, Machins, SJ.Arterial thrombosis, intrauterine death and ‘Lupus’ anticoagulant: Detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; 244–246.CrossRefGoogle ScholarPubMed
23.Walsh, FB, Hoyt, WF.Clinical Neuro-ophthalmology 1982; ed. Miller; Williams & Wilkins.Google Scholar